Kaletra (80 mg + 20 mg) / ml oral solution

Company:
AbbVie Limited
Status:
No Recent Update
Legal Category:
Product subject to restricted prescription (C)
Active Ingredient(s):
LopinavirRitonavir
*Additional information is available within the SPC or upon request to the company

Summary of Product Characteristics last updated on medicines.ie: 8/9/2023 Download PDF

Address: